Aptevo Therapeutics Inc. (APVO) Net income 2016–2025
Aptevo Therapeutics Inc. (APVO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$26.0MFY2025 · since FY2016: -$112.4M → -$26.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.0M | -7.6% |
| FY2024 | -$24.1M | -38.6% |
| FY2023 | -$17.4M | -316.9% |
| FY2022 | $8.0M | +128.2% |
| FY2021 | -$28.5M | -60.3% |
| FY2020 | -$17.8M | +56.1% |
| FY2019 | -$40.4M | +24.7% |
| FY2018 | -$53.7M | -870.0% |
| FY2017 | $7.0M | +106.2% |
| FY2016 | -$112.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice